Perceptive Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-152,714
Closed -$417K 115
2025
Q4
$417K Buy
+152,714
New +$353K 0.01% 113
2025
Q2
Sell
-12,711,788
Closed -$42.3M 97
2025
Q1
$42.3M Sell
12,711,788
-9,400,478
-43% -$48.5M 1.5% 17
2024
Q4
$164M Sell
22,112,266
-4,505,443
-17% -$41.8M 4.56% 6
2024
Q3
$250M Buy
26,617,709
+684,567
+3% +$6.49M 5.36% 4
2024
Q2
$208M Buy
25,933,142
+6,660,151
+35% +$71.4M 5.02% 4
2024
Q1
$286M Buy
19,272,991
+7,293,576
+61% +$84.9M 5.03% 3
2023
Q4
$97.4M Buy
11,979,415
+16,477
+0.1% +$86.2K 2.18% 10
2023
Q3
$54.4M Sell
11,962,938
-2,073,472
-15% -$13.5M 1.83% 16
2023
Q2
$98.8M Sell
14,036,410
-1,303,325
-8% -$9.33M 2.87% 6
2023
Q1
$93.7M Buy
15,339,735
+5,367,955
+54% +$37M 2.77% 10
2022
Q4
$63.7M Sell
9,971,780
-276,844
-3% -$2.16M 1.84% 20
2022
Q3
$98.2M Sell
10,248,624
-1,577,675
-13% -$18.2M 2.85% 11
2022
Q2
$131M Sell
11,826,299
-374,962
-3% -$4.91M 4.1% 5
2022
Q1
$203M Buy
12,201,261
+2,073,320
+20% +$32.1M 4.07% 5
2021
Q4
$193M Sell
10,127,941
-1,361,831
-12% -$30M 2.99% 6
2021
Q3
$283M Buy
11,489,772
+530,000
+5% +$12.5M 4.13% 5
2021
Q2
$285M Buy
10,959,772
+2,307,987
+27% +$60M 3.71% 5
2021
Q1
$274M Sell
8,651,785
-514,519
-6% -$21.3M 3.64% 5
2020
Q4
$425M Sell
9,166,304
-919,328
-9% -$36.5M 4.58% 5
2020
Q3
$332M Sell
10,085,632
-1,723,862
-15% -$52.8M 4.89% 4
2020
Q2
$324M Buy
11,809,494
+139,437
+1% +$4.58M 5.26% 4
2020
Q1
$349M Buy
11,670,057
+2,253,855
+24% +$59.7M 9.1% 1
2019
Q4
$261M Sell
9,416,202
-1,598,500
-15% -$36.4M 5.21% 5
2019
Q3
$200M Sell
11,014,702
-900,425
-8% -$19.9M 5.41% 4
2019
Q2
$292M Sell
11,915,127
-320,684
-3% -$4.83M 6.7% 4
2019
Q1
$116M Sell
12,235,811
-5,300
-0% -$51.5K 3.29% 7
2018
Q4
$108M Buy
12,241,111
+4,950,912
+68% +$47.7M 4.12% 5
2018
Q3
$82M Buy
7,290,199
+1,437,997
+25% +$20.4M 2.2% 9
2018
Q2
$74.9M Sell
5,852,202
-310,000
-5% -$4.53M 1.96% 10
2018
Q1
$104M Buy
6,162,202
+1,386,088
+29% +$21M 2.93% 7
2017
Q4
$38.2M Buy
4,776,114
+50,000
+1% +$401K 1.27% 19
2017
Q3
$36.6M Buy
4,726,114
+363,000
+8% +$2.3M 1.4% 15
2017
Q2
$32.1M Buy
4,363,114
+795,561
+22% +$5.06M 1.66% 16
2017
Q1
$26.6M Hold
3,567,553
1.52% 19
2016
Q4
$24.8M Hold
3,567,553
1.77% 13
2016
Q3
$29.4M Sell
3,567,553
-44,423
-1% -$376K 1.91% 11
2016
Q2
$29.3M Buy
3,611,976
+824,720
+30% +$5.18M 2.38% 11
2016
Q1
$14.2M Sell
2,787,256
-212,905
-7% -$1.17M 1.28% 19
2015
Q4
$23.2M Buy
3,000,161
+44,705
+2% +$310K 1.79% 15
2015
Q3
$17M Buy
2,955,456
+195,863
+7% +$1.53M 1.55% 19
2015
Q2
$25.3M Buy
2,759,593
+45,044
+2% +$503K 1.65% 13
2015
Q1
$32.9M Buy
+2,714,549
New +$30.6M 2.64% 6

Other funds holding IOVA